Position in VTGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$30,267
+$29,060 QoQ
Shares Held
53,100
+15750.7% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in VTGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,267 | 53,100 | Shares | Defined | 2026-05-13 | |
| 2023-03-31 | $1,207 | 10,065 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,006 | 10,065 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,509 | 10,065 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $8,857 | 10,065 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,480 | 10,065 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,626 | 10,065 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,153 | 11,370 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $39,469 | 12,530 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||